Skip to main navigation

4D Molecular Therapeutics

    About

  • About
    • Company Overview
    • Purpose & Strategy
    • Differentiation
    • FOUNDERS
    • Leadership Team
    • Board of Directors
    • CONTACT US
  • Technology

  • Technology
    • GENE THERAPY
    • Conventional Vectors
    • 4DMT Therapeutic Vector Evolution
    • Scientific Presentations
  • Product Pipeline

  • Product Pipeline
    • Pipeline Overview
    • Ophthalmological
    • Cardiology
    • Pulmonology
  • Partnerships

  • Partnerships
  • Patients & Advocacy

  • Patients & Advocacy
    • Overview
    • Advocacy Partners
    • Community Outreach
    • Patient Stories
    • Clinical Trials
    • Resources
    • Partner With Us
  • IR Nav

  • Investors & Media
    • Overview
    • Events & Presentations
    • Press Releases
    • SEC Filings
    • Stock Information
    • Analyst Coverage
    • Corporate Governance
  • Careers

  • Working at 4DMT
    • Corporate Culture
    • Current Openings
Menu

Investors & Media

Bio Details

Nancy Miller-Rich

Board Member
  • Member of the Compensation

Contacts

Media

Theresa Janke
tjanke@4dmt.com
415-321-9396

Investors

Mike Zanoni
Endurance Advisors
mzanoni@4dmt.com
610-442-8570

Request Email Alerts

 
Share

Social icons

Linkedin Facebook

    About

  • About
  • Technology

  • Technology
  • Product Pipeline

  • Product Pipeline
  • Partnerships

  • Partnerships
  • Patients & Advocacy

  • Patients & Advocacy
  • IR Nav

  • Investors & Media
  • Careers

  • Working at 4DMT
  • Home

  • Home
  • Terms of Use

  • Terms of Use
© 2021 4D Molecular Therapeutics, All Rights Reserved